Probiotix Health (AQSE:PBX) Accounts Receivable : £0.10 Mil (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Probiotix Health's accounts receivables for the quarter that ended in Jun. 2023 was £0.10 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Probiotix Health's Days Sales Outstanding for the quarter that ended in Jun. 2023 was 33.39.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Probiotix Health's Net-Net Working Capital per share for the quarter that ended in Jun. 2023 was £0.01.

Probiotix Health Accounts Receivable Historical Data

The historical data trend for Probiotix Health's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Accounts Receivable Chart

Probiotix Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec22

Accounts Receivable

0.35

Probiotix Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Accounts Receivable	Get a 7-Day Free Trial			-	-	0.51	0.35	0.10

Probiotix Health Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Probiotix Health Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Probiotix Health's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.101	/	0.552	*	91
=	33.39

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Probiotix Health's accounts receivable are only considered to be worth 75% of book value:

Probiotix Health's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1.948	+	0.75 * 0.101	+	0.5 * 0.077	-	0.67
-	0	-	0)	/	121.667
=	0.01

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Probiotix Health Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Probiotix Health's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Probiotix Health (AQSE:PBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

X90:Germany

Address

Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB

Website

https://www.probiotixhealth-ir.com

Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines